Latest Updates on Lipid Management

J 2019

Latest Updates on Lipid Management

EGOM, Emmanuel Eroume-A., Rebabonye B. PHARITHI, Soressa HESSE, Neasa STARR, Richard ARMSTRONG et. al.

Basic information

Original name

Latest Updates on Lipid Management

Authors

EGOM, Emmanuel Eroume-A. (372 Ireland), Rebabonye B. PHARITHI (372 Ireland), Soressa HESSE (372 Ireland), Neasa STARR (372 Ireland), Richard ARMSTRONG (372 Ireland), Habitha Mohammed SULAIMAN (372 Ireland), Katarina GAZDIKOVA (703 Slovakia), Ioana MOZOS (642 Romania), Martin CAPRNDA (703 Slovakia), Peter KUBATKA (703 Slovakia), Peter KRUŽLIAK (703 Slovakia, guarantor, belonging to the institution), Barkat KHAN (372 Ireland), Ludovit GASPAR (703 Slovakia) and Vincent M. G. MAHER (372 Ireland)

Edition

HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, NORTHCOTE, ADIS INT LTD, 2019, 1120-9879

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30212 Surgery

Country of publisher

New Zealand

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

RIV identification code

RIV/00216224:14110/19:00110192

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1007/s40292-019-00306-8

UT WoS

000463743900001

Keywords in English

ASCVD; Atherosclerotic cardiovascular disease; Cholesterol; Lipid management; Triglycerides

Abstract

V originále

Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death worldwide. Despite the clinical long-term and near-term benefits of lowering cholesterol in, respectively, primary and secondary prevention of ASCVD, cholesterol levels remain under-treated, with many patients not achieving their recommended targets. The present article will review the latest updates on lipid management with emphases on the different classes of cholesterol-lowering agents and their clinical uses.

Citovat

EGOM, Emmanuel Eroume-A., Rebabonye B. PHARITHI, Soressa HESSE, Neasa STARR, Richard ARMSTRONG, Habitha Mohammed SULAIMAN, Katarina GAZDIKOVA, Ioana MOZOS, Martin CAPRNDA, Peter KUBATKA, Peter KRUŽLIAK, Barkat KHAN, Ludovit GASPAR and Vincent M. G. MAHER. Latest Updates on Lipid Management. HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION. NORTHCOTE: ADIS INT LTD, 2019, vol. 26, No 2, p. 85-100. ISSN 1120-9879. Available from: https://dx.doi.org/10.1007/s40292-019-00306-8.

@article{1545968,
   author = {Egom, Emmanuel EroumeandA. and Pharithi, Rebabonye B. and Hesse, Soressa and Starr, Neasa and Armstrong, Richard and Sulaiman, Habitha Mohammed and Gazdikova, Katarina and Mozos, Ioana and Caprnda, Martin and Kubatka, Peter and Kružliak, Peter and Khan, Barkat and Gaspar, Ludovit and Maher, Vincent M. G.},
   article_location = {NORTHCOTE},
   article_number = {2},
   doi = {http://dx.doi.org/10.1007/s40292-019-00306-8},
   keywords = {ASCVD; Atherosclerotic cardiovascular disease; Cholesterol; Lipid management; Triglycerides},
   language = {eng},
   issn = {1120-9879},
   journal = {HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION},
   title = {Latest Updates on Lipid Management},
   url = {http://dx.doi.org/10.1007/s40292-019-00306-8},
   volume = {26},
   year = {2019}
}

TY  - JOUR
ID  - 1545968
AU  - Egom, Emmanuel Eroume-A. - Pharithi, Rebabonye B. - Hesse, Soressa - Starr, Neasa - Armstrong, Richard - Sulaiman, Habitha Mohammed - Gazdikova, Katarina - Mozos, Ioana - Caprnda, Martin - Kubatka, Peter - Kružliak, Peter - Khan, Barkat - Gaspar, Ludovit - Maher, Vincent M. G.
PY  - 2019
TI  - Latest Updates on Lipid Management
JF  - HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION
VL  - 26
IS  - 2
SP  - 85-100
EP  - 85-100
PB  - ADIS INT LTD
SN  - 11209879
KW  - ASCVD
KW  - Atherosclerotic cardiovascular disease
KW  - Cholesterol
KW  - Lipid management
KW  - Triglycerides
UR  - http://dx.doi.org/10.1007/s40292-019-00306-8
L2  - http://dx.doi.org/10.1007/s40292-019-00306-8
N2  - Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death worldwide. Despite the clinical long-term and near-term benefits of lowering cholesterol in, respectively, primary and secondary prevention of ASCVD, cholesterol levels remain under-treated, with many patients not achieving their recommended targets. The present article will review the latest updates on lipid management with emphases on the different classes of cholesterol-lowering agents and their clinical uses.
ER  -

EGOM, Emmanuel Eroume-A., Rebabonye B. PHARITHI, Soressa HESSE, Neasa STARR, Richard ARMSTRONG, Habitha Mohammed SULAIMAN, Katarina GAZDIKOVA, Ioana MOZOS, Martin CAPRNDA, Peter KUBATKA, Peter KRUŽLIAK, Barkat KHAN, Ludovit GASPAR and Vincent M. G. MAHER. Latest Updates on Lipid Management. \textit{HIGH BLOOD PRESSURE \&{}amp; CARDIOVASCULAR PREVENTION}. NORTHCOTE: ADIS INT LTD, 2019, vol.~26, No~2, p.~85-100. ISSN~1120-9879. Available from: https://dx.doi.org/10.1007/s40292-019-00306-8.

Detailed Information on Publication Record